Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea

URSAVAŞ, AHMET; KARADAĞ, MEHMET; Yılmaztepe Oral, ARZU; DEMİRDÖĞEN, EZGİ; ORAL, HALUK; Ege, Ercuement

doi:10.1016/j.rmed.2008.02.019

Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea

URSAVAŞ A., KARADAĞ M., Yılmaztepe Oral A., DEMİRDÖĞEN E., ORAL H. B., Ege E.

RESPIRATORY MEDICINE, cilt.102, sa.8, ss.1193-1197, 2008 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 102 Sayı: 8
Basım Tarihi: 2008
Doi Numarası: 10.1016/j.rmed.2008.02.019
Dergi Adı: RESPIRATORY MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1193-1197
Anahtar Kelimeler: obesity, sleep apnea, daytime sleepiness, neopterin, ACUTE CORONARY SYNDROMES, INSULIN-RESISTANCE, ARTERY-DISEASE, RISK-FACTOR, KAPPA-B, THICKNESS, MARKER, SYSTEM
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Objective: Obesity and obstructive sleep apnea (OSA) and systemic inflammation may interact through biochemical pathways. Neopterin (NP) is a monocyte/macrophage activation marker produced by macrophages in response to interferon-gamma secreted by activated T lymphocytes. This study examines the association between NP, obesity and OSA.